Hitzenberger G, Fitscha P, Beveridge T, Nuesch E, Pacha W
Br J Clin Pharmacol. 1982; 13(Suppl 2):217S-222S.
PMID: 7104143
PMC: 1402174.
DOI: 10.1111/j.1365-2125.1982.tb01914.x.
Kiowski W, Stumpe K, Buhler F
Eur J Clin Pharmacol. 1982; 21(6):445-9.
PMID: 7075649
DOI: 10.1007/BF00542036.
Bengtsson C, Lennartsson J, Lindquist O, Noppa H, Sigurdsson J
Eur J Clin Pharmacol. 1980; 17(3):173-7.
PMID: 6102518
DOI: 10.1007/BF00561896.
Doyle A
Drugs. 1974; 8(6):422-31.
PMID: 4156321
DOI: 10.2165/00003495-197408060-00006.
Weber M, Stokes G, Gain J
J Clin Invest. 1974; 54(6):1413-9.
PMID: 4154950
PMC: 301696.
DOI: 10.1172/JCI107888.
Beta-adrenergic receptor blocking drugs in hypertension.
Simpson F
Drugs. 1974; 7(1):85-105.
PMID: 4152167
DOI: 10.2165/00003495-197407010-00006.
Adverse reactions to beta-adrenergic receptor blocking drugs: a report from the Boston collaborative drug surveillance program.
Greenblatt D, Koch-Weser J
Drugs. 1974; 7(1):118-29.
PMID: 4151696
DOI: 10.2165/00003495-197407010-00008.
Beta-blockers and plasma renin activity in hypertension.
Stokes G, Weber M, Thornell I
Br Med J. 1974; 1(5897):60-2.
PMID: 4149613
PMC: 1632883.
DOI: 10.1136/bmj.1.5897.60.
[Effect of the beta-receptor-blocker prindolol on renal hypertension (author's transl)].
Undeutsch K, Sieberth H, MEURER K
Klin Wochenschr. 1976; 54(22):1077-84.
PMID: 1003866
DOI: 10.1007/BF01469111.
Beta-adrenergic receptor blocking drugs, hypertension and plasma renin.
Morgan T, Roberts R, Carney S, Louis W, Doyle A
Br J Clin Pharmacol. 1975; 2(2):159-64.
PMID: 791319
PMC: 1402516.
DOI: 10.1111/j.1365-2125.1975.tb01571.x.
Hypotensive effect of oxprenolol in mild to moderate hypertension: a multicentre controlled study.
Motolese M, MUIESAN G, Colombi A
Eur J Clin Pharmacol. 1975; 8(1):21-31.
PMID: 786673
DOI: 10.1007/BF00616411.
A double-blind crossover comparison of pindolol, metoprolol, atenolol and labetalol in mild to moderate hypertension.
McNeil J, Louis W
Br J Clin Pharmacol. 1979; 8(Suppl 2):163S-166S.
PMID: 43164
PMC: 1429742.
The second Lilly Prize Lecture, University of Newcastle, July 1977. beta-Adrenergic receptor blockade in hypertension, past, present and future.
Prichard B
Br J Clin Pharmacol. 1978; 5(5):379-99.
PMID: 26370
PMC: 1429347.
DOI: 10.1111/j.1365-2125.1978.tb01644.x.
Studies on the cardiovascular effects of pindolol in DOCA/saline hypertensive rats.
Buckingham R, Hamilton T, Robson D
Br J Pharmacol. 1977; 60(3):461-9.
PMID: 19118
PMC: 1667295.
DOI: 10.1111/j.1476-5381.1977.tb07523.x.
Side effects and contraindications of beta-receptor blocking agents.
LYDTIN H
Klin Wochenschr. 1977; 55(9):415-22.
PMID: 17766
DOI: 10.1007/BF01488578.
Hypertension: which beta-blocker?.
Drugs. 1976; 12(6):412-14.
PMID: 11985
DOI: 10.2165/00003495-197612060-00002.
Some aspects of the pharmacology of beta-adrenorecptor blockers.
Ablad B, Carlsson E, Dahlof C, Ek L
Drugs. 1976; 11 SUPPL 1:100-11.
PMID: 6242
DOI: 10.2165/00003495-197600111-00025.
A review of beta-blockers and their use in general practice.
Davies J
J R Coll Gen Pract. 1976; 26(164):219-26.
PMID: 4616
PMC: 2158047.
